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Abstract
OBJECTIVE: To investigate plasma samples from
neoplasm patients with phlegm-stasis or abnormal
Savda syndrome, with NMR spectroscopy, and to
analyze their metabolic varieties, characteristics
and reciprocity.
METHODS: 1H-NMR spectra were analyzed using
the orthogonal projection to latent structure with
discriminative analysis (OPLS-DA) method with unit
variance scaling. The discriminative significance of
metabolites was determined by the Pearson's prod-
uct–moment correlation coefficient.
RESULTS: Compared to the control group, neo-
plasm patients with phlegm– stasis or abnormal
Savda syndrome had low concentrations of leucine,
isoleucine, valine, alanine, tyrosine, histidine, citrul-
line, glycoprotein, glutamine, myo-inositol, scyl-
lo-inositol, creatine, α-glucose, β-glucose and lac-
tate (P<0.05), and high concentrations of very low
density lipoprotein, low density lipoprotein, unsatu-
rated lipid, formate, acetone, acetate, acetoacetate,
pyruvate, β-hydroxybutyrate, carnitine and malonic
acid (P<0.05), with no significant differences be-
tween the phlegm– stasis and abnormal Savda
syndrome patients.
CONCLUSIONS: Neoplasm patients with different
syndromes have very similar metabolic changes. A
series of abnormalities such as immune dysfunc-
tion and oxidative–antioxidative imbalance, occur
in neoplasm patients with abnormal Savda or
phlegm–stasis syndrome.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Traditional Chinese medicine and traditional Uyghur
medicine have different theoretical foundations due to
different cultural backgrounds and systems. Both
phlegm and stasis are characterized by different matters
and etiological factors in traditional Chinese medicine.
Phlegm forms from body fluid retention or accumula-
tion, or from metabolites that are not transported and
transformed normally, or results from water– electro-
lyte metabolism abnormality. Stasis is caused by block-
ing of blood circulation and pathological vascular
changes[1]. As a pathological outcome, phlegm and sta-
sis reciprocally transform under certain conditions and
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produce severe damage. Diseases with phlegm and sta-
sis have an extensive, complex and serious clinical ap-
pearance[1,2].
Body fluid (Hilit) theory is a basic theory of traditional
Uyghur Medicine. It is considered that Hilit is the ba-
sic matter during physiological activity, which is pro-
duced in the liver by various nutrient materials and
provides energy for the whole organism. According to
this theory, the Hilit includes Savda, Belghem, Sapra
and Kan, which circulate in the body continuously and
maintain the corresponding balance, inter-restriction
and complementation. Uyghur medicine considers
that abnormal changes in Hilit is the basis of disease,
which is called abnormal Hilit[3,4]. According to the de-
gree of change and disease symptoms, abnormal Hilit
is divided into abnormal Savda, Belghem, Sapra and
Kan. Abnormal Savda syndrome is a special syndrome
and is the foundation of complex diseases such as tu-
mor, diabetes mellitus, hypertension and asthma[5-7].
Phlegm and stasis are the pathological foundations of
complex diseases[1,2,8], and in traditional Uyghur medi-
cine, abnormal Savda is the foundation of disease[3,4,6].
Complex diseases have common pathogenesis and met-
abolic changes, which are the key to prevention and
treatment. Phlegm and stasis or abnormal Savda also re-
sult from metabolic abnormality, which appears in
body fluids such as urine and blood. Metabonomics is
a new method for the study of dynamic changes in the
endogenous metabolites in biosystems[9,10], and is an ide-
al tool for studying theories of traditional medicine. Al-
though phlegm– stasis and abnormal Savda are not
completely similar clinically, they do have similar
pathogenesis and pathophysiological changes[11,12].
In this study, we investigated plasma of neoplasm pa-
tients with phlegm– stasis and abnormal Savda syn-
drome, using nuclear magnetic resonance (NMR) spec-
troscopy, described the metabolic changes and charac-
teristics of neoplasm patients, and explained the reci-
procity of different symptoms with different theories.
MATERIALS ANDMETHODS
Sample preparation
Fifty healthy volunteers who were confirmed by medi-
cal examination and 354 neoplasm patients from the
Third Affiliated Hospital of Xinjiang Medical Universi-
ty were enrolled. The neoplasm patients were divided
into abnormal Savda syndrome by the theory of tradi-
tional Uyghur medicine[4,6] and phlegm– stasis syn-
drome by the theory of traditional Chinese medi cine
[13,14], There were 100 cases in the abnormal Savda syn-
drome group and 254 in the phlegm– stasis group.
Plasma samples were obtained by centrifugation of
blood samples from every individual in the morning
before breakfast, and were immediately stored at –80°
C until used for NMR spectroscopy.
1H-NMR spectroscopy of blood plasma
The plasma samples were prepared for NMR analysis
by mixing 200 μL plasma with 400 μL saline, and were
kept at room temperature for 10 min, before centrifu-
gation at 10,000 rpm for 10 min. The clear superna-
tant (550 μL) was placed in a 5-mm NMR tube for
spectroscopic analysis. The samples were analyzed by[1]
H-NMR spectroscopy at 500.13 MHz using a Bruker
500 (Rheinstetten, Germany) spectrometer at 298 K.
Water signals and broad protein resonances were sup-
pressed by a combination of presaturation and the Carr
–Purcell–Meiboom–Gill (CPMG) pulse sequence
(relaxation delay–90°– (τ–180°– τ)n-acquire). For
each sample, 64 scans were converted into 32,768 data
points over a spectral width of 20 ppm, which resulted
in an acquisition time of 1.64 s and relaxation delay of
2 s. For assignment purposes, several 2D NMR experi-
ments, including 1H-1H homonuclear correlation spec-
troscopy (COSY), total correlation spectroscopy (TOC-
SY) and J-resolved spectroscopy (J-Res), were also per-
formed for selected samples. For COSY and TOCSY
experiments, the spectral width was selected as 10 ppm
in both dimensions; the spectra resulted from 48 tran-
sients per increment and 256 increments were convert-
ed into 2048 data points. For J-Res experiments, there
were 32 transients per increment and 256 increments
were converted into 2048 data points with the spectral
width were 10 ppm of X dimension and 1.0 ppm of Y
dimension.
Spectral processing and data analysis
Before Fourier transformation, free induction decays
were multiplied by an exponential function equivalent
to a 1.0-Hz line-broadening factor. Fourier-trans-
formed 1H-NMR spectra were manually phased and
baseline-corrected within Topspin2.0 software (Version
2.0, Bruker Biospin, Rheinstetten, Germany). Chemi-
cal shifts were referenced to the anomeric proton of
α-glucose at δ5.233 ppm. The NMR spectra over the
range of δ 8.5–0.5 ppm were divided into 2834 inte-
grated regions of 0.003 ppm using AMIX (Version 3.8,
Bruker Biospin), and for each spectrum, all regions
were scaled by the total integrated area as a means for
normalization. The regions δH = 5.23 – 4.66 ppm
were excluded from the analysis because of the high
variability in the intensity of the water, and the regions
δH = 2.72–2.47 ppm was also removed due to the sig-
nals of the decoagulant.
Pattern recognition analysis was carried out on the nor-
malized NMR data sets using the SIMCA-P+ software
(Version 11.0, Umetrics Inc., Umeå, Sweden). We used
the orthogonal projection to latent structure with dis-
criminative analysis (OPLS-DA) method with unit
variance scaling[15]. OPLS-DA, a new method of data
analysis, is a combination of orthogonal signal correc-
tion with partial least squares analysis. Recently, it has
been reported that OPLS-DA results are more reliable
than principal component analysis (PCA) and simple
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independent modeling of class analogy (SIMCA) [16,17].
In this study, OPLS-DA comparisons between data of
NMR spectra were obtained from healthy controls and
neoplasm patients with different symptoms. In addi-
tion, a comparison between data of NMR spectra from
different symptom of neoplasm patients was also per-
formed. The OPLS-DA model was constructed using
the NMR data as the X matrix and class information
identifier for the different group as the Y variables, us-
ing one PLS and one orthogonal component[18]. The
quality of the OPLS-DA model was described by the
parameters R2X and Q2. R2X represented the total ex-
plained variation for the X matrix and Q2 indicated
the predictability of the model related to its statistical
validity. OPLS-DA coefficient plot was generated with
MATLAB (Version 7.0) scripts. The coefficient plot
showed that the variables contributed to classification,
and the significance of this contribution.
RESULTS
1H-NMR spectra of plasma samples
Typical examples of the plasma 1H-NMR spectra are
shown in Figure 1. Resonance assignments were made
by http://metabolomics.ca and confirmed by 2D
NMR methods such as COSY, TOCSY and J-Res spec-
tra. The metabolites confirmed in the plasma spectra
included several amino acids such as leucine, isoleu-
cine, valine, alanine, citrulline, tyrosine, histidine and
glutamine; a range of sugars including α-glucose and
β-glucose; lipid metabolites such as very low density li-
poprotein (VLDL), low density lipoprotein (LDL) and
unsaturated lipid; acidic metabolites such lactate, for-
mate, acetate, acetoacetate, pyruvate, malonic acid,
β-hydroxybutyrate; and another metabolites such as
glycoprotein, myo-inositol, scyllo-inositol, creatine, ac-
etone and carnitine.
Figure 1 (A): Three typical 1H-NMR 500-MHz spectra of plasma from healthy controls; (B): neoplasm patients with phlegm–stasis
syndrome; (C): neoplasm patients with abnormal Savda syndrome. The metabolites are listed in Table 1.
OPLS-DA of NMR spectra of plasma
To establish a global overview of the characteristics of
the neoplasm patients with different syndromes,
OPLS-DA was applied to the NMR data. Figure 2
shows the coefficient plots for the plasma. The values
of R2X and Q2 indicate the quality of the models. Q2
was used to provide an estimation of the predictive ca-
pability of the OPLS-DA models; Q2> 0.5 indicates
that the predictive capability of the model was good
and Q2> 0.9 was excellent[19]. According to the parame-
ters of the models of R2X and Q2, the OPLS-DA mod-
el reliably differentiated the neoplasm patients with
two different syndromes and healthy controls. The co-
efficient plots were color-coded with the absolute value
of the correlation coefficients. The direction of the sig-
nals in the coefficient plot indicated the changes in rela-
tive concentration of the metabolites in the class of in-
terest with respect to the other classes in the model.
The color of the signals in the coefficient plot repre-
sented the significance of the metabolites in the two
groups; red color indicated a more significant contribu-
tion to the class separation than did blue. The values of
the correlation coefficients indicating the significance
of the metabolites contributing to the separation for
each group are summarized in Table 1. Based on the
number of samples in each group, a correlation coeffi-
cient (determined by the Pearson's product–moment
correlation coefficient) of 0.273 was used as the cutoff
value for the statistical significance based on the dis-
crimination significance at the level of P=0.05. A posi-
tive value indicated a relatively lower concentration
and a negative value indicated a relatively greater con-
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centration of metabolites in the plasma of neoplasm pa-
tients with abnormal Savda or phlegm– stasis syn-
dromes.
These correlation coefficients showed that compared
with the control group, the neoplasm patients with ab-
normal Savda or phlegm– stasis syndrome had low
concentrations of leucine, isoleucine, valine, alanine, ty-
rosine, histidine, citrulline, glycoprotein, glutamine,
myo-inositol, scyllo-inositol, creatine, α-glucose, β-glu-
cose and lactate (r>0.273), but significantly high con-
centrations of VLDL, LDL, unsaturated lipid, formate,
acetone, acetate, acetoacetate, pyruvate, β-hydrocxy bu-
tyrate, carnitine and malonic acid (r<– 0.273). Data
analysis showed that the neoplasm patients with abnor-
mal Savda or phlegm–stasis syndrome had changes in
glycometabolism, amino acid and fat metabolism.
Figure 2 (A): Coefficient plot of 1H-NMR spectra of plasma with phlegm–stasis syndrome compared with healthy controls; (B): Co-
efficient plot of 1H-NMR spectra of plasma with abnormal Savda syndrome compared with healthy controls. The color scale shows
the significance of metabolite variations between the two classes; the metabolite numbers are listed in Table 1.
Table 1 Comparison of plasma metabolites and correlation coefficients in the neoplasm patients with abnormal Savda or phlegm
–stasis syndrome and healthy controls
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Metabolite
leucine
isoleucine
valine
alanine
citrulline
glycopro-
tein
glutamine
β-glucose
α-glucose
scyllo-inosi-
tol
myo-inosi-
tol
tyrosine
histidine
lactate
creatine
formate
lipid
(VLDL)
unsaturat-
ed lipid
lipid(LDL)
Chemical shift (ppm)
0.95(d),0.97(d),1.72(m),3.68(dd)
0.93(t),1.00(d),1.96(m)
0.98(d),1.04(d),2.27(d),3.60(d)
1.47(d),3.76(q)
1.88(m)
2.03(s)
2.10(m),2.14(m),2.42(m),3.76(m)
3.24(dd),3.40(t),3.47(ddd),3.49(t)
3.70(dd),3.90(dd),4.64(d)
3.53(dd),3.72(dd),5.23(d)
3.35(s)
3.65(dd)
3.05(dd),3.20(dd),3.95(dd),6.88(d)
7.18(d)
3.14(dd),3.25(dd),3.98(dd),7.03(s)
7.73(s)
1.33(d),4.11(q)
3.03(s),3.93(s)
8.45(s)
0.85(m),0.88(m),1.27(m),1.57(m)
2.00(m) 2.22(m)
5.26(m),5.28(m),5.30(m),5.32(m)
1.26(m),4.24(m)
Assignment
δ-CH3,δ-CH3,β-CH2,α-CH
δ-CH3,β-CH3,β-CH
CH3,CH3,β-CH2,α-CH2
CH3,α-CH
β-CH2
NHCO-CH3
half β-CH2, half β-CH2, half
γ-CH2,α-CH
C-H2,C-H4,C-H5,C-H3,
C-H6, half CH2-CH6,C-H1
C-H2,half CH2-CH6,C-H1
ring proton
H4/H6
half β-CH2,CH2,α-CH, H3/H5
H2/H6
half β-CH2,half β-CH2,α-CH,
H4, H2
CH3,CH
CH3,CH2
CH
CH3(CH2)n,CH3CH2CH2C=,
CH2CH2CO,CH3CH2(CH2)n,
CH2C=C, CH2CO
=CHCH2CH=, =
CHCH2CH2=, =
CHCH2CH2=, =CHCH2CH2=
CH3CH2(CH2)n,CH2OCOR
*Coefficient (r)
Healthy/abnormal
savda
0.61
0.78
0.77
0.83
0.55
0.46
0.72
0.55
0.66
0.52
0.57
0.61
0.72
0.5
0.43
-0.82
-0.46
-0.48
-0.42
Healthy/
Tanyu
0.51
0.75
0.76
0.78
0.5
0.38
0.69
0.5
0.64
0.51
0.55
0.53
0.69
0.53
0.39
-0.71
-0.4
-0.45
-0.35
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20
21
22
23
24
25
26
acetone
acetate
acetoacetate
pyruvate
β-hydrocxy
butyrate
carnitine
malonic ac-
id
2.22(s)
1.91(s)
2.27(s)
2.38(s)
1.19(d),2.30(dd),2.41(dd),4.16(d)
2.46(dd)
3.12(s)
CH3
CH3
CH3
CH3
γ-CH3,half α-CH2,CH2,β-CH
CH2(COO)
CH2
-0.8
-0.78
-0.72
-0.82
-0.67
-0.92
-0.83
-0.83
-0.69
-0.64
-0.7
-0.56
-0.85
-0.69
Note: Multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; m, multilet; dd, doublet of doublets; ddd, doublet of doublets of doublets.
The coefficients from OPLS-DA results; positive and negative signs indicate positive and negative correlation in the concentrations, respec-
tively.
DISCUSSION
It has been shown previously that there are different
metabolic characteristics in neoplasm patients with ab-
normal Savda and abnormal Unsavda (including abnor-
mal Belghem, Sapra and Kan)[20], which is proof of the
biological foundation of traditional medicine theory.
Therefore, our purpose was to study the biological
foundation of disorders in the body and to look for the
basis of the theory, "different diseases are based on simi-
lar reasons"[6,21].
We used NMR-based metabonomics to find the bio-
chemical changes in neoplasm patients with different
syndromes. Concentrations of the metabolites β-hy-
droxybutyrate, acetoacetate and acetone increased in
the plasma of neoplasm patients with abnormal Savda
or phlegm–stasis syndrome, as compared with healthy
persons. Ketone bodies are intermediate products of
fatty acid metabolism and enter the blood after produc-
tion in the liver. Usually, they are present at low levels
in the blood, but this level increases with fat metabo-
lism[22]. Organs outside the liver produce a large quanti-
ty of acetyl coenzyme A, which uses the ketone bodies
and inhibits pyruvate dehydrogenase, so that pyruvate
cannot enter the Krebs cycle and its plasma concentra-
tion increases. There was also an increase in the blood
concentration of fat-related metabolites such as acetic
acid, unsaturated lipids, VLDL and LDL in neoplasm
patients with abnormal Savda or phlegm– stasis syn-
drome, along with an increase in formic and malonic
acids, indicating that fat mobilization was increased.
Lower levels of creatine and myo-inositol are also relat-
ed to fat mobilization. Carnitine is the main carrier of
acetyl coenzyme A during fat metabolism, and is in-
volved in the biosynthesis and oxidation of fatty acids.
A decrease in carnitine concentration also indicates in-
creased fat metabolism.
α-Glucose, β-glucose and the non-oxidative product
lactate were decreased significantly in neoplasm pa-
tients with abnormal Savda or phlegm– stasis syn-
drome compared with healthy controls. It is assumed
that patients with abnormal Savda or phlegm– stasis
syndrome rely on fat metabolism as their main source
of energy.
We observed that the plasma concentration of various
amino acids including leucine, alanine, citrulline, tyro-
sine, histidine, isoleucine and valine decreased signifi-
cantly in neoplasm patients with different syndromes.
The metabolites related to cell membrane protection
and immune function, such as glutamine, myo-inosi-
tol, scyllo-inositol and creatine, also decreased in the
plasma. The immune system is the main antitumor de-
fense system in the body, and glutamine maintains the
function of the immune system and increases the total
lymphocyte count combined with glycoprotein and ala-
nine. Glutamine also protects cells, tissues and organs
from damage by free radicals. Decreased plasma gluta-
mine indicates a decrease in cell antioxidant activity,
cell membrane damage, immune dysfunction, free radi-
cal injury, and intensified oxidative damage. Some stud-
ies have demonstrated that abnormal Savda or phlegm
– stasis syndrome produces many oxygen free radi
cals[7], which is the main cause of oxidant–antioxidant
imbalance. Therefore, it is thought that a series of ab-
normalities such as immune dysfunction and oxi-
dant-antioxidant imbalance occur in abnormal Savda
or phlegm–stasis syndrome.
We showed that neoplasm patients with different syn-
dromes had similar metabolic changes to those in
healthy controls. Moreover, OPLS-DA analysis could
not distinguish between neoplasm patients with differ-
ent syndromes. However, although abnormal Savda
and phlegm–stasis syndromes are not similar clinical-
ly, they do have similar etiological factors and popula-
tion distribution[7]. Our results indicate that abnormal
Savda and phlegm–stasis syndromes have a significant
reciprocal effect on body metabolism. According to the
theory, "different diseases are based on similar rea-
sons", abnormal Savda and phlegm– stasis syndromes
are the pathological foundation of complex and refrac-
tory diseases.
In conclusion, differences in the plasma metabolite pro-
files between neoplasm patients with different syn-
dromes and healthy controls were identified with an
NMR-based metabonomic strategy. Even if abnormal
Savda (traditional Uyghur medicine) and phlegm–sta-
sis syndromes (traditional Chinese medicine) belong to
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different theoretical systems of medicine, they lead to
similar metabolic disorders, including disorders of fat,
glucose and amino acid metabolism. Cell membrane
disorders and immune dysfunction also occur in pa-
tients with abnormal Savda or phlegm– stasis syn-
drome. Therefore, it is believed that abnormal Savda
and phlegm– stasis are descriptions of similar symp-
toms in different theory systems.
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